iSAM Funds (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,080
Closed -$1.03M – 323
2026
Q2
$1.03M Buy
2,080
+1,330
+177% +$589K 0.73% 29
2026
Q1
$335K Sell
750
-2,471
-77% -$1.15M 0.17% 186
2025
Q4
$1.46M Buy
3,221
+1,971
+158% +$850K 0.53% 59
2025
Q3
$490K Buy
+1,250
New +$522K 0.1% 276
2024
Q4
– Sell
-1,051
Closed -$489K – 418
2024
Q3
$489K Buy
+1,051
New +$505K 0.28% 142
2024
Q2
– Sell
-2,015
Closed -$842K – 378
2024
Q1
$842K Buy
+2,015
New +$852K 0.48% 75

Other funds holding VRTX

iSAM Funds (UK)'s VRTX Position: Q3 2026 in Review

iSAM Funds (UK) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 2,080 shares — an estimated $1.03M sold.

iSAM Funds (UK) first reported a position in VRTX in Q1 2024 and held it in 6 quarters. The position peaked at $1.46M in Q4 2025. 1,775 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • iSAM Funds (UK) reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 2,080 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.03M.
  • iSAM Funds (UK) first reported a position in Vertex Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • iSAM Funds (UK)'s Vertex Pharmaceuticals position peaked at $1.46M in Q4 2025.
  • 1,775 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on iSAM Funds (UK)'s 13F filing for Q3 2026, filed 16 Nov 2026.